Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


08.01.2018

1 Ann Agric Environ Med
1 Anticancer Res
1 Biosci Rep
1 Br J Radiol
1 Brachytherapy
1 Ceska Gynekol
1 Cochrane Database Syst Rev
1 Glob Health Sci Pract
1 Int J Clin Oncol
3 Int J Gynecol Cancer
1 J Cancer
2 J Clin Virol
2 J Community Health
2 J Gynecol Oncol
1 J Minim Invasive Gynecol
1 J Public Health (Oxf)
1 J Xray Sci Technol
1 Magn Reson Med
1 Malawi Med J
1 Med Sci Monit
1 Nan Fang Yi Ke Da Xue Xue Bao
2 Oncol Res
3 Oncotarget
1 Patient Educ Couns


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Agric Environ Med

  1. SKORZYNSKA H, Krawczyk-Suszek M, Kulik TB, Pacian A, et al
    Attitudes of women after the age of 50 towards preventive screening.
    Ann Agric Environ Med. 2017;24:624-627.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. OKONOGI N, Wakatsuki M, Kato S, Shiba S, et al
    Long-term Outcomes of Carbon-ion Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Uterine Cervix.
    Anticancer Res. 2018;38:457-463.
    PubMed     Text format     Abstract available


    Biosci Rep

  3. ZHU X, Zhou L, Li R, Shen Q, et al
    AGER promotes proliferation and migration in cervical cancer.
    Biosci Rep. 2018 Jan 3. pii: BSR20171329. doi: 10.1042/BSR20171329.
    PubMed     Text format     Abstract available


    Br J Radiol

  4. GULER OC, Torun N, Yyldyrym BA, Onal C, et al
    Pretreatment metabolic tumor volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy.
    Br J Radiol. 2018 Jan 2:20170552. doi: 10.1259/bjr.20170552.
    PubMed     Text format     Abstract available


    Brachytherapy

  5. SHAW W, Rae WID, Alber ML
    Image-guided adaptive brachytherapy dose escalation for cervix cancer via fractionation compensation.
    Brachytherapy. 2017;16:534-546.
    PubMed     Text format     Abstract available


    Ceska Gynekol

  6. SLAMA J
    [Current limits of cervical cancer prevention in the Czech republic].
    Ceska Gynekol. 2017;82:482-486.
    PubMed     Text format     Abstract available


    Cochrane Database Syst Rev

  7. KYRGIOU M, Athanasiou A, Kalliala IEJ, Paraskevaidi M, et al
    Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease.
    Cochrane Database Syst Rev. 2017;11:CD012847.
    PubMed     Text format     Abstract available


    Glob Health Sci Pract

  8. CREMER M, Paul P, Bergman K, Haas M, et al
    A Non-Gas-Based Cryotherapy System for the Treatment of Cervical Intraepithelial Neoplasia: A Mixed-Methods Approach for Initial Development and Testing.
    Glob Health Sci Pract. 2017;5:57-64.
    PubMed     Text format     Abstract available


    Int J Clin Oncol

  9. XIE X, Song K, Cui B, Jiang J, et al
    A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.
    Int J Clin Oncol. 2018 Jan 3. pii: 10.1007/s10147-017-1225.
    PubMed     Text format     Abstract available


    Int J Gynecol Cancer

  10. HARTMAN CA, Teixeira JC, Barbosa SB, Figueiredo SM, et al
    Analysis of Conservative Surgical Treatment and Prognosis of Microinvasive Squamous Cell Carcinoma of the Cervix Stage IA1: Results of Follow-Up to 20 Years.
    Int J Gynecol Cancer. 2017;27:357-363.
    PubMed     Text format     Abstract available

  11. GUO X, Dong Z, Yamada S, Li Y, et al
    Association of Casp3 microRNA Target Site (1049216) SNP With the Risk and Progress of Cervical Squamous Cell Carcinoma.
    Int J Gynecol Cancer. 2017;27:206-213.
    PubMed     Text format     Abstract available

  12. CHONG GO, Lee YH, Lee HJ, Hong DG, et al
    Comparison of the Long-Term Oncological Outcomes Between the Initial Learning Period of Robotic and the Experienced Period of Laparoscopic Radical Hysterectomy for Early-Stage Cervical Cancer.
    Int J Gynecol Cancer. 2018 Jan 4. doi: 10.1097/IGC.0000000000001172.
    PubMed     Text format     Abstract available


    J Cancer

  13. EO WK, Kwon BS, Kim KH, Kim HY, et al
    Monocytosis as a prognostic factor for survival in stage IB and IIA cervical cancer.
    J Cancer. 2018;9:64-70.
    PubMed     Text format     Abstract available


    J Clin Virol

  14. GHOSH I, Muwonge R, Mittal S, Banerjee D, et al
    Association between high risk human papillomavirus infection and co-infection with Candida spp. and Trichomonas vaginalis in women with cervical premalignant and malignant lesions.
    J Clin Virol. 2017;87:43-48.
    PubMed     Text format     Abstract available

  15. LEINONEN MK, Schee K, Jonassen CM, Lie AK, et al
    Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions.
    J Clin Virol. 2017;99-100:22-30.
    PubMed     Text format     Abstract available


    J Community Health

  16. KELLY PJ, Hunter J, Daily EB, Ramaswamy M, et al
    Challenges to Pap Smear Follow-up among Women in the Criminal Justice System.
    J Community Health. 2017;42:15-20.
    PubMed     Text format     Abstract available

  17. LAI D, Bodson J, Davis FA, Lee D, et al
    Diverse Families' Experiences with HPV Vaccine Information Sources: A Community-Based Participatory Approach.
    J Community Health. 2017;42:400-412.
    PubMed     Text format     Abstract available


    J Gynecol Oncol

  18. PRETI M, Bucchi L, Ghiringhello B, Privitera S, et al
    Risk factors for unrecognized invasive carcinoma in patients with vulvar high-grade squamous intraepithelial lesion at vulvoscopy-directed biopsy.
    J Gynecol Oncol. 2017;28:e27.
    PubMed     Text format     Abstract available

  19. LEE HJ, Lee JJ, Park JY, Kim JH, et al
    Prognostic value of metabolic parameters determined by preoperative (1)(8)F-FDG PET/CT in patients with uterine carcinosarcoma.
    J Gynecol Oncol. 2017;28:e43.
    PubMed     Text format     Abstract available


    J Minim Invasive Gynecol

  20. YIM GW, Eoh KJ, Chung YS, Kim SW, et al
    Perioperative Outcomes of 3-Arm Versus 4-Arm Robotic Radical Hysterectomy in Patients with Cervical Cancer.
    J Minim Invasive Gynecol. 2017 Dec 26. pii: S1553-4650(17)31338.
    PubMed     Text format     Abstract available


    J Public Health (Oxf)

  21. NGWENYA D, Huang SL
    Knowledge, attitude and practice on cervical cancer and screening: a survey of men and women in Swaziland.
    J Public Health (Oxf). 2017 Dec 27. pii: 4779874. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Xray Sci Technol

  22. PENG J, Wang W, Zeng D
    Application of magnetic resonance imaging in diagnosis of Uterus Cervical Carcinoma.
    J Xray Sci Technol. 2017;25:205-211.
    PubMed     Text format     Abstract available


    Magn Reson Med

  23. DUAN C, Kallehauge JF, Bretthorst GL, Tanderup K, et al
    Are complex DCE-MRI models supported by clinical data?
    Magn Reson Med. 2017;77:1329-1339.
    PubMed     Text format     Abstract available


    Malawi Med J

  24. MOSES A, Mwafongo A, Chikasema M, Kafantenganji L, et al
    Risk factors for common cancers among patients at Kamuzu Central Hospital in Lilongwe, Malawi: A retrospective cohort study.
    Malawi Med J. 2017;29:136-141.
    PubMed     Text format     Abstract available


    Med Sci Monit

  25. JIN Y, Qiu S, Shao N, Zheng J, et al
    Fucoxanthin and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Synergistically Promotes Apoptosis of Human Cervical Cancer Cells by Targeting PI3K/Akt/NF-kappaB Signaling Pathway.
    Med Sci Monit. 2018;24:11-18.
    PubMed     Text format     Abstract available


    Nan Fang Yi Ke Da Xue Xue Bao

  26. CHEN JW, Chen HB, He Q, Liao YL, et al
    [Rectal toxicity prediction based on accurate rectal surface dose summation for cervical cancer radiotherapy].
    Nan Fang Yi Ke Da Xue Xue Bao. 2017;37:1626-1631.
    PubMed     Text format     Abstract available


    Oncol Res

  27. SHI X, Yuan N, Zhang S, Yuan F, et al
    MicroRNA-379 suppresses cervical cancer cell proliferation and invasion by directly targeting V-crk avian sarcoma virus CT10 oncogene homolog-like.
    Oncol Res. 2018 Jan 2. doi: 10.3727/096504017X15140534417184.
    PubMed     Text format     Abstract available

  28. WANG Y, Tian Y
    miR-206 inhibits cell proliferation, migration, and invasion by targeting BAG3 in human cervical cancer.
    Oncol Res. 2018 Jan 2. doi: 10.3727/096504017X15143731031009.
    PubMed     Text format     Abstract available


    Oncotarget

  29. PLISSONNIER ML, Fauconnet S, Bittard H, Mougin C, et al
    Cell death and restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer cells.
    Oncotarget. 2017;8:107744-107762.
    PubMed     Text format     Abstract available

  30. MATSUO K, Shimada M, Yokota H, Satoh T, et al
    Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer.
    Oncotarget. 2017;8:106866-106875.
    PubMed     Text format     Abstract available

  31. MEI Y, Peng C, Liu YB, Wang J, et al
    Silencing RIF1 decreases cell growth, migration and increases cisplatin sensitivity of human cervical cancer cells.
    Oncotarget. 2017;8:107044-107051.
    PubMed     Text format     Abstract available


    Patient Educ Couns

  32. MATTINGLY M, Juran R, Su I, Ebinger J, et al
    Patient knowledge of hysterectomy and pap screening after minimally invasive hysterectomy.
    Patient Educ Couns. 2017;100:121-125.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: